Skip Navigation

European Heart Journal 2004 25(15):1364-1365; doi:10.1016/j.ehj.2004.05.026
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Eriksson, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Eriksson, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letter to the Editor

Long-term clopidogrel therapy in the drug eluting stent era: beyond CREDO and CURE-PCI: Reply

Peter Eriksson

Interventional Cardiology Laboratory, Heart Centre, University Hospital, S-901 85 Umea, Sweden Tel.: +46-907-856925; fax: +46-901-37633

E-mail address: peter.eriksson@medicin.umu.se

The first 10% of the full text of this article appears below.

Sir

In the trials comparing drug-eluting stents with bare metal stents, clopidogrel (in addition to aspirin) had been administrated for 2–6 months, and no increase in the incidence of stent thrombosis has . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?